Friday, July 10, 2026
🇺🇸 FDA

pharma · No medical condition. · No medical condition

Tillomed Laboratories

Laboratorios Tillomed Spain S.L.U

Tillomed Laboratories clinical programs — 51 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.

Website Investor relations
Luton, GB HQ
1 Employees
EMA registrant Type
Company details
Status
Public
HQ
Luton, GB
Employees
1
Programs
51
Drugs
75
Patents
0
Official website ↗ All projects Drug pipeline News & analysis

Recent coverage

View all news & analysis →
Intelligence · Clinical Programs

Tillomed Laboratories projects

51 ClinicalTrials.gov programs sponsored by Tillomed Laboratories.

Tillomed Laboratories has 51 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.

All phases Phase III Phase II Phase I NDA / BLA filed Approved programs

51 programs

Clinical programs

Page 1 of 2

  1. CLOBOF3-17IA03

    Laboratorios Tillomed Spain S.L.U

    Inflammation and pain associated with ocular surgery

    phase 3 small molecule active

    1 trial

  2. 1019/25

    Laboratorios Tillomed Spain S.L.U

    Bioavailability study in healthy volunteers under fed conditions.

    phase 1 other active

    1 trial

  3. 1062/25

    Laboratorios Tillomed Spain S.L.U

    Bioavailability study in healthy volunteers under fasting conditions.

    phase 1 other active

    1 trial

  4. 2025-LIUD06004-PL-01

    Laboratorios Tillomed Spain S.L.U

    No medical condition.

    phase 1 other active

    1 trial

  5. BLCL-2ME-01

    Laboratorios Tillomed Spain S.L.U

    No medical condition.

    phase 1 other active

    1 trial

  6. BLCL-2ME-02

    Laboratorios Tillomed Spain S.L.U

    No medical condition.

    phase 1 other active

    1 trial

  7. BLCL-ACB-PIL01

    Laboratorios Tillomed Spain S.L.U

    No medical condition.

    phase 1 other active

    1 trial

  8. BLCL-ETN-ANV-01

    Laboratorios Tillomed Spain S.L.U

    No medical condition

    phase 1 other active

    1 trial

  9. BLCL-ETN-ANV-02

    Laboratorios Tillomed Spain S.L.U

    No medical condition.

    phase 1 other active

    1 trial

  10. Bioequivalence clinical trial of two formulations of linagliptin/metformin

    Laboratorios Tillomed Spain S.L.U

    Healthy volunteers

    phase 1 other active

    1 trial

  11. Bioequivalence clinical trial of two formulations of bilastine.

    Laboratorios Tillomed Spain S.L.U

    Healthy volunteers

    phase 1 other active

    1 trial

  12. Bioequivalence clinical trial of two formulations of canagliflozin

    Laboratorios Tillomed Spain S.L.U

    Healthy volunteers

    phase 1 other active

    1 trial

  13. Bioequivalence clinical trial of two formulations of dapagliflozin.

    Laboratorios Tillomed Spain S.L.U

    Healthy volunteers

    phase 1 other active

    1 trial

  14. Bioequivalence clinical trial of two formulations of dapagliflozin/metformin

    Laboratorios Tillomed Spain S.L.U

    Healthy volunteers

    phase 1 other active

    1 trial

  15. Bioequivalence clinical trial of two formulations of dapagliflozin/metformin

    Laboratorios Tillomed Spain S.L.U

    Healthy volunteers

    phase 1 other active

    1 trial

  16. Bioequivalence clinical trial of two formulations of edoxaban.

    Laboratorios Tillomed Spain S.L.U

    Healthy volunteers

    phase 1 other active

    1 trial

  17. Bioequivalence clinical trial of two formulations of ezetimibe/atorvastatin

    Laboratorios Tillomed Spain S.L.U

    Healthy volunteers

    phase 1 other active

    1 trial

  18. Bioequivalence clinical trial of two formulations of linagliptin

    Laboratorios Tillomed Spain S.L.U

    Healthy volunteers

    phase 1 other active

    1 trial

  19. Bioequivalence clinical trial of two formulations of linagliptin

    Laboratorios Tillomed Spain S.L.U

    Healthy volunteers

    phase 1 other active

    1 trial

  20. Bioequivalence clinical trial of two formulations of linagliptin/metformin.

    Laboratorios Tillomed Spain S.L.U

    Healthy volunteers

    phase 1 other active

    1 trial

  21. Bioequivalence clinical trial of two formulations of loperamide.

    Laboratorios Tillomed Spain S.L.U

    Healthy volunteers

    phase 1 other active

    1 trial

  22. Bioequivalence clinical trial of two formulations of loperamide.

    Laboratorios Tillomed Spain S.L.U

    Healthy volunteers

    phase 1 other active

    1 trial

  23. Bioequivalence clinical trial of two formulations of loperamide.

    Laboratorios Tillomed Spain S.L.U

    Healthy volunteers

    phase 1 other active

    1 trial

  24. Bioequivalence clinical trial of two formulations of loperamide.

    Laboratorios Tillomed Spain S.L.U

    Healthy volunteers

    phase 1 other active

    1 trial

  25. Bioequivalence clinical trial of two formulations of rosuvastatin.

    Laboratorios Tillomed Spain S.L.U

    Hypercholesterolemia

    phase 1 other active

    1 trial

  26. Bioequivalence clinical trial of two formulations of vortioxetine.

    Laboratorios Tillomed Spain S.L.U

    Healthy volunteers

    phase 1 other active

    1 trial

  27. Bioequivalence of Testosterone Transdermal Gel in Healthy Female Participants.

    Laboratorios Tillomed Spain S.L.U

    No medical conditions.

    phase 1 other active

    1 trial

  28. CFA-1028-2-23

    Laboratorios Tillomed Spain S.L.U

    No medical condition.

    phase 1 other active

    1 trial

  29. CFA-1034-1-23

    Laboratorios Tillomed Spain S.L.U

    No medical condition

    phase 1 other active

    1 trial

  30. CFA-1034-2-23

    Laboratorios Tillomed Spain S.L.U

    No medical condition.

    phase 1 other active

    1 trial

  31. CFA-1037-1-24

    Laboratorios Tillomed Spain S.L.U

    No medical condition.

    phase 1 other active

    1 trial

  32. CFA-1042-1-24

    Laboratorios Tillomed Spain S.L.U

    No medical condition

    phase 1 other active

    1 trial

  33. CFA-1042-3-26

    Laboratorios Tillomed Spain S.L.U

    No medical condition

    phase 1 other active

    1 trial

  34. CFA-1048-1-25

    Laboratorios Tillomed Spain S.L.U

    No medical condition.

    phase 1 other active

    1 trial

  35. CFA-1048-2-25

    Laboratorios Tillomed Spain S.L.U

    No medical condition.

    phase 1 other active

    1 trial

  36. CFA-1048-3-25

    Laboratorios Tillomed Spain S.L.U

    No medical condition.

    phase 1 other active

    1 trial

  37. LT-02-19

    Laboratorios Tillomed Spain S.L.U

    Chronic spontaneous urticaria, Allergic asthma, Chronic rhinosinusitis with nasal polyps

    phase 1 other active

    1 trial

  38. Levodopa 250mg and Carbidopa 25mg Test Drug tablet

    Laboratorios Tillomed Spain S.L.U

    Bioequivalence

    phase 1 small molecule completed

    1 trial

  39. SIE-1

    Laboratorios Tillomed Spain S.L.U

    Hormone receptor-positive early breast cancer in post-menopausal women

    phase 1 other active

    1 trial

  40. The bioavailability study of Dapagliflozin

    Laboratorios Tillomed Spain S.L.U

    not applicable (submitted trial is a bioequivalence study

    phase 1 other active

    1 trial

  41. TioSMI

    Laboratorios Tillomed Spain S.L.U

    Chronic obstructive pulmonary disease

    phase 1 other active

    1 trial

  42. UECHUP-ATO/24-3

    Laboratorios Tillomed Spain S.L.U

    Hypercholesterolaemia, Prevention of cardiovascular disease

    phase 1 other active

    1 trial

  43. UECHUP-DAP/24-4

    Laboratorios Tillomed Spain S.L.U

    Diabetes

    phase 1 other active

    1 trial

  44. UECHUP-DON/23-5

    Laboratorios Tillomed Spain S.L.U

    Alzheimer's disease

    phase 1 other active

    1 trial

  45. UECHUP-EDO/25-2

    Laboratorios Tillomed Spain S.L.U

    Healthy volunteers

    phase 1 other active

    1 trial

  46. UECHUP-ESC/25-3

    Laboratorios Tillomed Spain S.L.U

    Antidepressants

    phase 1 other active

    1 trial

  47. UECHUP-LIN-MET/24-1

    Laboratorios Tillomed Spain S.L.U

    diabetes

    phase 1 other active

    1 trial

  48. UECHUP-MEM/25-6

    Laboratorios Tillomed Spain S.L.U

    Alzheimer’s disease

    phase 1 other active

    1 trial

Frequently asked questions

How many clinical projects does Tillomed Laboratories have?

51 published programs are linked to this sponsor in our ClinicalTrials.gov index.

Is this the complete company pipeline?

This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.